Michael Kauffman, MD and CEO from Karyopharm Therapeutics Inc discusses Selinexor its mechanism of action and as it restores the activity of tumor-suppressant proteins at the 2017 American Society of Hematology.
Selinexor is Mechanism of Action It restores the activity of tumor-suppressant proteins
